Childhood Acute Lymphoblastic Leukemia: Is There a Tumor Suppressor Gene in Chromosome 12p 12.3 ?

Leukemia and Lymphoma

Volumn 34, Issue 42067, 1999, Pages 231-239

  Aissani B ^a   Bonan, C ^a   Baccichet, A ^a   Sinnett, D ^a,b  

^a Centre de Recherche   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

acute lymphoblasic leukemia; ALL; childhood acute leukemia; chromosome 12p12.3; ETV6 TEL; p27 kipl; physical map; tumor suppressor locus

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA MARKER; TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILDHOOD LEUKEMIA; CHROMOSOME 12P; CHROMOSOME DELETION; CPG ISLAND; GENETIC LINKAGE; HEMATOLOGIC DISEASE; HETEROZYGOSITY LOSS; HUMAN; LEUKEMIA CELL; PRIORITY JOURNAL; RESTRICTION MAPPING; REVIEW; SEQUENCE TAGGED SITE; TUMOR SUPPRESSOR GENE;

CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; DNA-BINDING PROTEINS; GENE REARRANGEMENT; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LOSS OF HETEROZYGOSITY; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0344069783     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199909050948     Document Type: Article

References (70)

1. Greaves M. A natural history for pediatric acute leukemia. Blood 1993; 82: 1043 – 1051
2. Lococo F., Saglio G. Single or multiple origin of hemopoietic tumors: the contribution of clonality studies. Leukemia 1995; 9: 1586 – 1589
3. Weinberg R. A. Oncogenes, anti-oncogenes, and the molecular basis of multistep carcinogenesis. Cancer Research 1989; 49: 3713 – 3721
4. Vogelstein B., Kinzler K. W. The multistep nature of cancer. Trends in Genetics 1993; 9: 138 – 141
5. Cleary M. L. Oncogenic conversion of transcription factors by chromosomal translocations. Cell 1991; 67: 619 – 622
6. Rabbitts T. H. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 1991; 67: 641 – 644
7. Rabbitts T. H. Chromosomal translocations in human cancer. Nature 1994; 372: 143 – 149
8. Prigogina E. L., Puchkova G. P., Mayakova S. A. Nonrandom chromosomal abnormalities in acute lymphoblastic leukemia of childhood. Cancer Genetics and Cytogenetics 1988; 32: 183 – 203
9. Johansson B., Mertens F., Mitelman F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes and Cancer 1993; 8: 205 – 218
10. Raimondi S. C. Current status of cytogenetic research in childhood acute lymphoblastic. Blood 1993; 81: 2237 – 2251
11. Champlin R., Gale R. P. Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 1989; 73: 2051 – 2066
12. Cayuela J. M., Madani A., Sanhes L., Stem M. H., Sigaux F. Multiple tumor- suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 1996; 87: 2180 – 2186
13. Chen Y. C., Chen P. J., Yeh S. H., Tien H. F., Wang C. H., Tang J. L., Hong R. L. Deletion of the human ret-inoblastoma gene in primary leukemias. Blood 1990; 76: 2060 – 2064
14. Schottelius A., Brennscheidt U., Ludwig W. D., Mertels-Mann R. H., Herrmann F., Lubbert M. Mechanisms of p53 alteration in acute leukemias. Leukemia 1994; 8: 1673 – 1681
15. Berger R., Bemheim A., Leconiat M., Vecchione D., Pacot A., Daniel M., And T., Flandrin G. Abnormalities of the short arm of the chromosome 12 in acute non-lymphoblastic leukemia and dysmyelopoietic syndrome. Cancer Genetics and Cytogenetics 1986; 19: 281 – 289
16. Raimondi S. C., Wiliams D. L., Callihan T., Peiper S., Rivera G. K., Murphy S. B. Nonrandom involvement of 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 1986; 68: 69 – 75
17. Mitelman F. Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. S. Karger AG., Basel, Switzerland 1991
18. Chan L. C., Kwong Y. L., Liu H. W., Lee C. P., Chan A. Y. Y. Deletion 12p in de novo acute myeloid leukemia (an association with early progenitor cell). Cancer Genetics and Cytogenetics 1992; 62: 47 – 49
19. Takeuchi S., Bartram C. R., Wada M., Reiter A., Hatta Y., Seriu T., Lee E., Miller C. W., Miyoshi I., Koeffler H. P. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Research 1995; 55: 5377 – 5382
20. Cavé H., Guidal C., Elion J., Vilmer E., Grandchamp B. A low rate of loss of heterozygosity is found at many different loci in childhood B-lineage acute lymphocytic leukemia. Leukemia 1996; 10: 1486 – 1491
21. Baccichet A., Qualman S. K., Sinnett D. Allelic loss in childhood acute lymphoblastic leukemia. Leukemia Research 1997a; 21: 817 – 823
22. Knudson A. G. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Science USA 1971; 68: 820 – 823
23. Stegmaier K., Pendse S., Barker G. F., Bray-Ward P., Ward D. C., Montgomery K. T., Krauter K. S., Reynolds C., Sklar J., Donnelly M., Bohlander S. K., Rowley J. D., Sallan S. E., Gilliland D. G., Golub T. R. Frequent loss of heterozygosity at the EL gene locus in acute lymphoblastic leukemia in childhood. Blood 1995; 86: 38 – 44
24. Sato Y., Suto Y., Pietenpol J., Golub T. R., Gilliland D. G., Davis E. M., Lebeau M. M., Roberts J. M., Vogelstein B., Rowley J. D., Bohlander S. K. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 1995; 86: 1525 – 1533
25. Takeuchi S., Bartram C. R., Miller C. W., Reiter A., Seriu T., Zimmermann M., Schrappe M., Mori N., Slater J., Miyoshi I., Koeffler H. P. Acute lymphoblastic leukemia of childhood: Identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood 1996a; 87: 3368 – 3374
26. Baccichet A., Sinnett D. Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukemia. British Journal of Haematology 1997b; 99: 107 – 114
27. Kobayashi H., Montgomery K. T., Bohlander S. K., Adra C. N., Lim B. L., Kucherlapati R. S., Donis-Keller H., Holt M. S., Le Beau, And M. M., Rowley J. D. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 1994; 84: 3473 – 3482
28. Kucherlapati R., Marynen P., Turc-Carel C. Report of the fourth international workshop on human chromosome 12 mapping 1997. Cytogenetics and Cell Genetics 1997; 78: 81 – 95
29. Polyak K., Lee M. H., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P., Massagui J. Cloning of p27KIO1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59 – 66
30. Toyoshima H., Hunter T. P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 67 – 74
31. Krauter K., Montgomery K., Yoon S. J., Leblanc-Straceski J., Renault B., Marondel I., Herdman V., Cupelli L., Banks A., Lieman J., Menninger I., Bray-Ward P., Nad-Kami P., Weissenbach J., Le Paslier D., Rigault P., Chuma-Kov I., Cohen D., Miller P., Ward D., Kucherlapati R. A second-generation YAC contig map of human chromosome 12. Nature 1995; 377 (supp.) 321 – 333
32. Hudson T. J., Stein L. D., Gerety S. S., Ma J., Castle A. B., Silva J., Slonim D. K., Baptista R., Kruglyak L., Xu S.-H., Hu X., Colbert A. M. E., Rosenberg C., Reeve-Daly M. P., Rozen S., Hui L., Wu X., Vestergaard C., Wilson K. M., Bae J. S., Maitra S., Ganiatsas S., Evans C. A., Dean-Gelis M. M., Ingalls K. A., Nahf R. W., Horton L. T., Jr., Oskin Anderson M., Collymore A. J., Ye W., Kouyoum-Ijian V., Zemsteva J. S., Tam J., Devine R., Courtney D. F., Turner Renaud M., Nguyen H., Oconnor T. J., Fizames C., Fauré S., Gyapay G., Dib C., Morissette J., Orlin J. B., Birren B. W., Goodman N., Weissenbach J., Hawkins T. L., Foote S., Page D. C., Lander E. S. An STS-based map of the human genome. Science 1995; 270: 1945 – 1954
33. Pietenpol J. A., Bohlander S. K., Sato Y., Papadopoulos N., Liu B., Friedman C., Trask B. J., Roberts J. M., Kin-Zler K. W., Rowley J. D., Vogelstein B. Assignment of the human p27KIP1 gene to 12∼13 and its analysis in leukemias. Cancer Research 1995; 55: 1206 – 1210
34. Ponce-Castaneda M. V., Lee M. H., Latres E., Polyak K., Lacombe L., Montgomery K., Mathew S., Krauter K., Sheinfeld J., Massague J., Cordon-Cardo C. p27KIP1: chromosomal mapping to 12p12–12p13.1 and absence of mutations in human tumors. Cancer Research 1995; 55: 1211 – 1214
35. Golub T. R., Barker G. F., Lovett M., Gilliland D. G. Fusion of PDGF receptor beta to a novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5, 12) chromosomal translocation. Cell 1994; 77: 307 – 316
36. Golub T. R., McLean T., Stegmaier K., Carroll M., Tomas-Son M., Gilliland D. G. The TEL gene and human leukemia. Biochimica et Biophysica Acta 1996; 1288, M7–M10.
37. Buijs A., Sherr S., Van Baal S., Van Bezouw S., Van Der Plas D., Van Kessel A. G., Riegman P., Lekanne Deprez R., Zwarthoff E., Hagemeijer A., Grosveld G. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN gene on 22q11. Oncogene 1995; 10: 1511 – 1519
38. Peeters P., Wlodarska I., Baens M., Criel A., Selleslag D., Hagemeijer A., Van Den Berghe H., Marynen P. Fusion of ETV6 to MDS1/EV11 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Cancer Research 1997; 57: 564 – 569
39. Papadopoulos P., Ridge S. A., Boucher C. A., Stocking C., Wiedernann L. M. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Research 1995; 55: 34 – 38
40. Wlodarska I., Mecucci C., Marynen P., Guo C., Franckx D., Lastarza R., Aventin A., Bosly A., Martelli M. F., Cassiman J. J., Van Den Berghe H. TEL gene is involved in Myelodysplastic Syndromes with either the typical t(5;12)(q33;p13) translocations or its variant t(10;12)(q24;p13). Blood 1995; 85: 2848 – 2852
41. Golub T. R., Barker G. F., Bohlander S. K., Hiebert S. W., Ward D. C., Bray-Ward P., Morgan E., Raimondi S. C., Rowley J. D., Gilliland D. G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Science USA 1995; 92: 4917 – 4921
42. Shurtleff S. A., Buijs A., Behm F. G., Rubnitz J. E., Raimondi S. C., Hancock M. L., Chan G. C. F., Pui C.-H., Grosveld G., Downing J. R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985 – 1989
43. Romana S. P., Poirel H., Leconiat M., Flexor M. A., Mauchauffé M., Jonveaux P., Macintyre E. A., Berger R., Bernard J. A. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263 – 4269
44. Raynaud S., Mauvieux L., Cayuela J. M., Bastard C., Bilhou-Nabera C., Debuire B., Bones D., Boucheix C., Char-Rin C., FiÈRe D., Gabert J. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 1996a; 10: 1529 – 1530
45. Shih L.-Y., Chou T.-B., Liang D.-C., Tzeng Y.-S., Rubnitz J. E., Downing J. R., Pui C.-H. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996; 10: 1456 – 1458
46. Loh M. L., McLean T. W., Buckley J. D., Howells W., Gilliland D. G., Smith F. O. Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEWAML1. Leukemia Research 1998; 22: 461 – 464
47. Rubnitz J. E., Shuster J. J., Land V. J., Link M. P., Pullen D. J., Camitta B. M., Pui C.-H., Downing J. R., Behm F. G. Case-control study suggests a favorable impact of “EL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A pediatric oncology group study. Blood 1997; 89: 1143 – 1146
48. McLean T. W., Ringold S., Neuberg D., Stegmaier K., Tantravahi R., Ritz J., Koeffler H. P., Takeuchi S., Janssen J. W. G., Sen T., Bartram C. R., Sallan S. E., Gilliland D. G., Golub T. R. TELIAML-1 dimerizes and is associated with a favorable outcome in childhood acute lym-phoblastic leukemia. Blood 1996; 88: 4252 – 4258
49. Lanza C., Volpe G., Basso G., Gottardi E., Barisone E., Spinelli M., Ricotti E., Cilli V, Perfetto F., Madon E., Saglio G. Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. British Journal of Haematology 1997; 97: 460 – 162
50. Harbott J., Viehmann S., Borkardt A., Henze G., Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 1997; 90: 4933 – 4937
51. Leconiat M., Della Valle V., Marynen P., Berger R. A new breakpoint, telomeric to TEL/ETV6, on the short arm of chromosome 12 in T cell acute lymphoblastic leukemia. Leukemia 1997; 11: 1360 – 1363
52. Sato Y., Bohlander S. K., Kobayashi H., Reshmi S., Suto Y., Davis E. M., Espinosa R., III, Hoopes R., Montgomery K. T., Kucherlapati R. S., Lebeau M. M., Rowley J. D. Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6) is involved in only one half. Blood 1997; 90: 4886 – 4893
53. Crepieux P., Coll J., Stehelin D. The ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Critical Reviews in Uncogenesis 1994; 5: 615 – 638
54. Raynaud S., Cavé H., Baens M., Bastard C., Cacheux V., Grosgeorge J., Guidal-Giroux C., Guo C., Vilmer E., Marynen P., Grandchamp B. The 12;21 translo-cation involving TEL Allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996b; 87: 2891 – 2899
55. Takeuchi S., Seriu T., Bartram C. R., Golub T. R., Reiter A., Miyoshi I., Gilliland D. G., Koeffler H. P. TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia. Leukemia 1997; 11: 1220 – 1223
56. Raimondi S. C., Shurtleff S. A., Downing J. R., Rubnitz J., Mathew S., Hancock M., Pui C.-H., Rivera G. K., Grosveld G. C., Behm F. G. 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia. Blood 1997; 90: 4559 – 4566
57. Romana S. P., Leconiat M., Poirel H., Marynen P., Brenard O. A., Berger R. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 1996; 10: 167 – 170
58. Stegmaier K., Takeuchi S., Golub T. R., Bohlander S. K., Bartram C. R., Koeffler H. P., Gilliland D. G. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Research 1996; 56: 1413 – 1417
59. Höglund M., Johansson B., Pedersen-Bjergaard J., Marynen P., Mitelman F. Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 1996; 87: 324 – 330
60. Andreasson P., Johansson B., Arheden K., Billstrom R., Mitelman F., HÖGlund M. Deletions of CDKNIB and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosomes and Cancer 1997; 19: 77 – 83
61. Spirin K. S., Simpson J. F., Takeuchi S., Kawamata N., Miller C. W., Koeffler H. P. p27/Kipl mutation found in breast cancer. Cancer Research 1996; 56: 2400 – 2404
62. Takeuchi S., Mori N., Koike M., Slater J., Park S., Miller C. W., Miyoshi I., Koeffler H. P. Frequent loss of heterozygosity in region of the KIP1 in non-small cell lung cancer: Evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res 1996b; 56: 738 – 740
63. Hatta Y., Takeuchi S., Yokota J., Koeffler H. P. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3–13.1 (region of TEL and Kip1 loci) and chromosome 12q23-tecevidence for two new tumour-suppressor genes. British Journal of Cancer 1997; 75: 1256 – 1262
64. Aïssani B., Bonan C., Sinnett D. Fine physical and transcript mapping of a 1.8Mb region spanning the locus for childhood acute lymphoblastic leukemia on chromosome 12p12.3. 1998, submitted).
65. Sinnett D., Wagstaff J., Glatt K., Woolf E., Kirkness E. J., Lalande M. High-resolution mapping of the γ-aminobutyric acid receptor subunit β3 and α5 gene cluster on chromosome 15q11-q13, and localization of breakpoints in two Angelman syndrome patients. American Journal of Human Genetics 1993; 52: 1216 – 1229
66. Bird P. A. CpG islands as gene markers in the vertebrate nucleus. Trends in Genetics 1987; 3: 324 – 347
67. Larsen R, Gundersen G., Lopez R., Prydz H. CpG islands as gene markers in the human genome. Genomics 1992; 13: 1095 – 1107
68. Watanabe T. K., Shimizu F., Nagata M., Takaichi A., Fugiwara T., Nakamura Y., Takashi E., Hirai Y. Cloning, expression pattern and mapping to 12p13.2-p13.1 of CLAPS3, a gene encoding a novel clathrin-adaptor small chain. Cyrogenetics and Cell Genetics 1996; 73: 214 – 217
69. Hoornaert I., Marynen P., Baens M. CREBL2, a novel transcript from the chromosome 12 region flanked by ETV6 and CDKNIB. Genomics 1998; 51: 154 – 157
70. Gyapay G., Morissette J., Vigna A., Dib C., Fizames C., Millasseau P., Marc S., Bemardi G., Lathrop M., Weis-Senbach J. The 1993–1994 genethon human genetic linkage map. Nature Genetics 1994; 7: 246 – 339